Taking on Europe's third leading cause of death
Agreement to include research funding for chronic lung diseases is hailed by the leading scientific society in respiratory medicine The European Respiratory Society (ERS), the leading international medical and scientific society in the field of respiratory medicine, today hailed new support for lung research.
The European Parliament vote on FP7 (the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities 2007- 13) has secured vital funding for research into chronic lung diseases. According to Professor William MacNee, President of the ERS, this represents "an important step forward, as the FP7 will offer valuable opportunities to consolidate Europe-wide expertise using multidisciplinary approaches to tackle chronic respiratory diseases".
